bioMerieux SA (BIM) News
Follow bioMerieux SA (BIM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
BIMobject Q3 Net Sales Rise 9% as EBITDA Loss Narrows
EQUITY | Oct 22, 2026, 06:22 AM UTC
M
Bimobject Reports Q3 Net Sales of SEK 44.4 Million
EARNINGS | Oct 22, 2026, 06:09 AM UTC
M
BioMerieux gets IVDR Class D CE mark for two syndromic tests
BioMerieux says it has received IVDR Class D CE marking for two syndromic tests, including a MERS-CoV test.
REGULATION | Sep 16, 2026, 05:40 AM UTC
L
BIMobject LTIP 2023 warrant exercises add 3,508,825 shares
From 26 May to 26 August 2026, 3,508,825 LTIP 2023 warrants were exercised at BIMobject, with 2,758,825 exercised in June and 750,000 in August, leading to subscription of a corresponding number of shares.
EQUITY | Sep 02, 2026, 03:00 PM UTC
L
BIMobject expands Prodikt ecosystem with three new data partners
BIMobject said it is expanding the Prodikt ecosystem with three new data partners.
EQUITY | Aug 27, 2026, 06:30 AM UTC